Next Breath Receives ISO/IEC 17025:2005 Accreditation from the Perry Johnson Laboratory Accreditation, INC
Baltimore, Maryland (PRWEB) December 25, 2013 -- Next Breath, LLC, a Specialty Contract Research Organization (CRO) with expertise in analytical testing of pulmonary, nasal drug, and ophthalmic delivery systems, announced today that the company received its ISO (the International Organization for Standardization) and IEC (the International Electrotechnical Commission) 17025:2005 accreditation from the Perry Johnson Laboratory Accreditation. Compliance with this standard provides a globally accepted basis for laboratory accreditation. The standard specifies the management and technical requirements to be met by testing and calibration laboratories in both the organization and management of quality.
The ISO/IEC 17025:2005 also covers testing and calibration performed using standard methods, non-standard methods, and laboratory-developed methods. This accreditation is another illustration of Next Breath’s commitment to quality and technical expertise, and adherence to the highest standards in quality management systems.
Julie Suman, President, says, “We are very pleased with this accreditation, which confirms Next Breath’s commitment to meeting and exceeding the highest quality standards. We work diligently to maintain regulatory standards and we have once again demonstrated our ability to sustain and continuously improve quality systems within our organization.”
About Perry Johnson Laboratory Accreditation
Perry Johnson Laboratory Accreditation, Inc. (PJLA) is a private organization, offering third-party accreditation services for testing and calibration laboratories. We are absolutely committed to meeting and exceeding the requirements and expectations of our clients in terms of the quality of the services we provide. We are a fully recognized accreditation body by the International Laboratory Accreditation Cooperation (ILAC) and by the Asia Pacific Laboratory Accreditation Cooperation (APLAC) to provide testing and calibration accreditation services
About Next Breath
Next Breath, a member of the AptarGroup, is a cGMP contract services organization for pharmaceutical, biotech and medical device companies that bring pulmonary, nasal, and ophthalmic drug products to market. Next Breath provides comprehensive solutions to the development processes from proof of concept to commercialization. Next Breath has led successful submissions for pulmonary and nasal drug products and devices in the US and international markets.
About Next Breath
Next Breath, a member of the AptarGroup, is a cGMP contract services organization for pharmaceutical, biotech and medical device companies that bring pulmonary, nasal, and ophthalmic drug products to market. Next Breath provides comprehensive solutions to the development processes from proof of concept to commercialization. Next Breath has led successful submissions for pulmonary and nasal drug products and devices in the US and international markets.
For more information please visit http://www.nextbreath.net or http://www.aptar.com.
Contact Next Breath
Badre Hammond, MBA
+(1)352-642-2141 / badre.hammond(at)nextbreath(dot)net
Badre E. Hammond, MBA, [email protected], http://www.nextbreath.net/, +1 (443) 543-5809, [email protected]
Share this article